Related Experiment Video
Updated: Feb 16, 2026

13:01
gP2S, an Information Management System for CryoEM Experiments
Published on: June 10, 2021
5.9K
25th Conference of GP2A.
Michael D Threadgill1, Susan E Matthews2, Francesca Giuntini3
1Drug & Target Discovery, Department of Pharmacy & Pharmacology, University of Bath, Bath BA2 7AY, UK. m.d.threadgill@bath.ac.uk.
Pharmaceuticals (Basel, Switzerland)
|December 15, 2017
Summary
The 25th GP2A conference convened medicinal chemists to share insights on bioactive compounds and drug design. Young scientists presented research on natural products and therapeutic development.
Area of Science:
- Medicinal Chemistry
- Drug Discovery
- Natural Products
Background:
- The 25th Conference of the GP2A (Groupement des Pharmaciens-Préparateurs d'Avenir) focused on knowledge exchange in medicinal chemistry.
- The event specifically aimed to foster collaboration among young medicinal chemists.
Framework:
- The conference facilitated discussions on bioactive compounds derived from plants and lichens.
- Key themes included the design and development of novel therapeutic agents.
- Abstracts covered invited lectures, oral presentations, flash presentations, and posters.
Implementation:
- The conference was held in Liverpool, UK, on August 31 and September 1, 2017.
- It served as a platform for presenting and discussing cutting-edge research in drug discovery.
- Young researchers were a central focus for idea exchange and experience sharing.
Implications:
- The proceedings offer a snapshot of current trends and research in medicinal chemistry and drug development.
- The collected abstracts highlight advancements in understanding and utilizing bioactive compounds.
- The event underscored the importance of nurturing young talent in the field of pharmaceutical sciences.
Related Concept Videos
GTPases and their Regulation
9.9K
Guanine nucleotide-binding proteins (G-proteins), also known as GTPases, are a superfamily of proteins that regulate many cellular processes, such as cell signaling, vesicular transport, and the regulation of cell shape and motility. Mutation or dysfunction of these proteins can lead to disease. There are around 40,000 known G-proteins that can broadly be classified into two groups ‒ small G-proteins consisting of a single domain and large multi-domain G-proteins.
Large G-proteins,...
Large G-proteins,...
9.9K
GTPases and their Regulation
3.0K
3.0K
GPCRs Regulate Adenylyl Cylase Activity
7.7K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
7.7K
Coat Assembly and GTPases
4.5K
Vesicles incorporate different coat protein subunits in different cell locations, which changes the properties of the coat, such as the shape and geometry of the transport vesicles. Thus, vesicle coat proteins also play a significant role in cargo selection.
Coat assembly depends on the local availability of phosphatidylinositol phosphates or PIPs and GTP-binding proteins. Adaptor proteins, which link the coat proteins to the membrane, bind to these PIPs and play a crucial role in controlling...
Coat assembly depends on the local availability of phosphatidylinositol phosphates or PIPs and GTP-binding proteins. Adaptor proteins, which link the coat proteins to the membrane, bind to these PIPs and play a crucial role in controlling...
4.5K
GPCR Desensitization
8.3K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
8.3K

![Automated Preparation of [68Ga]Ga-3BP-3940 on a Synthesis Module for PET Imaging of the Tumor Microenvironment](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F68356.jpg&w=3840&q=50)